Drug – bio-affecting and body treating compositions – Radionuclide or intended radionuclide containing; adjuvant... – In an organic compound
Reexamination Certificate
2011-03-15
2011-03-15
Jones, D L (Department: 1618)
Drug, bio-affecting and body treating compositions
Radionuclide or intended radionuclide containing; adjuvant...
In an organic compound
C424S001110, C424S001650, C424S009100
Reexamination Certificate
active
07906102
ABSTRACT:
A method for identifying a molecule that binds an irradiated tumor in a subject and molecules identified thereby. In some embodiments, the method includes the steps of (a) exposing a tumor to ionizing radiation; (b) administering to a subject a library of diverse molecules; and (c) isolating from the tumor one or more molecules of the library of diverse molecules, whereby a molecule that binds an irradiated tumor is identified. Also provided are targeting ligands that bind an irradiated tumor and therapeutic and diagnostic methods that employ the disclosed targeting ligands.
REFERENCES:
patent: 6159443 (2000-12-01), Hallahan
patent: 6277974 (2001-08-01), Lo
patent: 7049140 (2006-05-01), Hallahan
patent: 7402392 (2008-07-01), Hallahan et al.
patent: 2002/0164663 (2002-11-01), Fuqua et al.
patent: 2003/0083261 (2003-05-01), Yu et al.
patent: 2007/0065361 (2007-03-01), Hallahan
patent: 2008/0206130 (2008-08-01), Hallahan et al.
International Search Report for corresponding PCT Appl. No. PCT/US02/30917 dated Feb. 10, 2005.
Hallahan et al., “Targeting Drug Delivery to Radiation-induced Neoantigens in Tumor Microvasculature”,Journal of Controlled Release, 74: 183-191, 2001.
Hallahan et al., “X-Ray-induced P-Seectin Localization to the Lumen of Tumor Blood Vessels”,Cancer Research, 58: 5216-5220, Nov. 15, 1998.
Lieberman et al., “A Human Homolog of the Schizosaccharomyces Pombe rad9 Check Point Control Gene”,Proceedings of the National Academy of Sciences, 93: 13890-13895, Nov. 1996.
Database HCAPLUS on STN, ACS (Columbus, OH, USA) No. 2001:661624, Xu et al., “Cell Cycle Proteins PP5 Associated with rad9 and Uses in Screening for a Bioactive Agent”, Abstract, WO 01/64913, see Registry No. 263887-03-2, human gene rad9, for SEQ ID No. 8.
Database HCAPLUS on STN, ACS (Columbus, OH, USA) No. 1997:513697, Dolganov, “The Human rad50 and Septin-2 Genes and their Roles in Myelodysplastic diseases and their Diagnostic and Therapeutic Uses”, Abstract, WO 97/27284, see Registry No. 194813-18-8, human clone B15.2, for SEQBID No. 8.
Database HCAPLUS on STN, ACS (Columbus, OH, USA) No. 2000:573954, Kastan et al., “ATM Kinase Modulation for Screening and Therapies”, WO 00/47760, see Registry No. 288259-02-9 for SEQ ID No. 8 and 10 and Registry No. 288259-18-7 for SEQ ID No. 13.
Database HCAPLUS on STN, ACS (Columbus, OH, USA) No. 1998:248017, Kurnik et al., “Prospective Study of Atrial Natriuretic Peptide for the Prevention of Radio-Contrast-Induced Nephropathy”, Abstract,American Journal of Kidney Diseases, 1998, see Registry No. 95896-08-5, atrial natriuretic peptide-25, for SEQ ID No. 11.
Database HCAPLUS on STN, ACS (Columbus, OH, USA) No. 1998:365000, Croce et al., “Cloning of Human rad54 Gene Homolog and its Diagnostic and Therapeutic uses”, EP 844,305, see Registry No. 208601-90-5, human rad54, for SEQ ID No. 12.
Pasqualini et al.Molecular Psychiatry, vol. 1, (1996), p. 423.
Barry et al. Toward cell-targeting gene therapy vectors: Selection of cell-binding peptides from random peptide-presenting phage libraries.Nature Medicine, vol. 2, No. 3, (1996), pp. 299-305.
Notification of Transmittal of the International Search Report and the Written Opinion of the International Searching Authority for corresponding PCT Appl. No. PCT/US06/27283 dated Mar. 13, 2007.
Notification Concerning Transmittal of International Preliminary Report on Patentability for International Application No. PCT/US2006/027283 (Jan. 24, 2008).
Hallahan Dennis E.
Han Zhaozhong
Qu Shimian
Jones D L
Vanderbilt University
LandOfFree
Ligands to radiation-induced molecules does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Ligands to radiation-induced molecules, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Ligands to radiation-induced molecules will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-2782827